Your browser doesn't support javascript.
loading
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study.
Li, Jin; Qin, Shukui; Wen, Lu; Wang, Junsheng; Deng, Wenying; Guo, Weijian; Jia, Tongfu; Jiang, Da; Zhang, Guifang; He, Yifu; Ba, Yi; Zhong, Haijun; Wang, Lin; Lin, Xiaoyan; Yang, Jianwei; Zhao, Jun; Bai, Yuxian; Wu, Xiangyuan; Gao, Feng; Sun, Guogui; Wu, Yongjuan; Ye, Feng; Wang, Qiong; Xie, Zhong; Yi, Tienan; Huang, Yong; Yu, Guohua; Lu, Lin; Yuan, Ying; Li, Wei; Liu, Likun; Sun, Yuping; Sun, Ying; Yin, Lifeng; Hou, Zhiguo.
Afiliación
  • Li J; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
  • Qin S; Department of Oncology, Cancer Center of Jinling Hospital, Nanjing University of Chinese Medicine, No. 34 Biao, 34 Hao, Yanggongjing Road, Qinhuai District, Nanjing, 210002, Jiangsu Province, China. qinsk@csco.org.cn.
  • Wen L; Department of Gastroenterology, Shanxi Provincial Cancer Hospital, Taiyuan, China.
  • Wang J; Department of Internal Medicine, Anyang Cancer Hospital, Anyang, China.
  • Deng W; Department of Gastroenterology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • Guo W; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Jia T; Department of Oncology, ZiBo Central Hospital, Zibo, China.
  • Jiang D; Department of Oncology, The Fourth Hospital of Hebei Medical University & Hebei Cancer Hospital, Shijiazhuang, China.
  • Zhang G; Department of Oncology, Xinxiang Central Hospital, Xinxiang, China.
  • He Y; Department of Oncology, The First Affiliated Hospital of USTC West District & Anhui Provincial Cancer Hospital, Hefei, China.
  • Ba Y; Department of Digestive Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
  • Zhong H; Department of Medical Oncology, Zhejiang Cancer Hospital, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, China.
  • Wang L; Department of Oncology, Cancer Center of Jinling Hospital, Nanjing University of Chinese Medicine, No. 34 Biao, 34 Hao, Yanggongjing Road, Qinhuai District, Nanjing, 210002, Jiangsu Province, China.
  • Lin X; Department of Medical Oncology, Fujian Medical University Affiliated Union Hospital, Fuzhou, China.
  • Yang J; Department of Abdominal Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
  • Zhao J; Department of Oncology, Changzhi People's Hospital, Changzhi, China.
  • Bai Y; Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Wu X; Department of Oncology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Gao F; Department of Oncology, Heilongjiang Agricultural Reclamation Bureau General Hospital, Harbin, China.
  • Sun G; Department of Radiotherapy and Chemotherapy, Tangshan People's Hospital, Tangshan, China.
  • Wu Y; Department of Digestive Oncology, Baotou Tumor Hospital, Baotou, China.
  • Ye F; Department of Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Wang Q; Department of Oncology, Jiangyin People's Hospital, Jiangyin, China.
  • Xie Z; Department of Oncology, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • Yi T; Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
  • Huang Y; Department of Oncology, The Second People's Hospital of Hefei, Hefei, China.
  • Yu G; Department of Oncology, Weifang People's Hospital, Weifang, China.
  • Lu L; Department of Oncology, 105 Hospital of People's Liberation Army, Hefei, China.
  • Yuan Y; Department of Oncology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
  • Li W; Department of Oncology, The First Hospital of Jilin University, Changchun, China.
  • Liu L; Department of Oncology, Shanxi Traditional Chinese Medical Hospital, Taiyuan, China.
  • Sun Y; Department of Oncology, Central Hospital Affiliated To Shandong First Medical University, Jinan, China.
  • Sun Y; Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China.
  • Yin L; Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China.
  • Hou Z; Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China.
BMC Med ; 21(1): 173, 2023 05 05.
Article en En | MEDLINE | ID: mdl-37147645
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Adenocarcinoma / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Adenocarcinoma / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article